Mechanistically Probing Lipid-siRNA Nanoparticle-associated Toxicities Identifies Jak Inhibitors Effective in Mitigating Multifaceted Toxic Responses
Open Access
- 1 March 2011
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 19 (3) , 567-575
- https://doi.org/10.1038/mt.2010.282
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Lipid-like materials for low-dose, in vivo gene silencingProceedings of the National Academy of Sciences, 2010
- Evaluation of Efficacy, Biodistribution, and Inflammation for a Potent siRNA Nanoparticle: Effect of Dexamethasone Co-treatmentMolecular Therapy, 2010
- Development of Lipidoid–siRNA Formulations for Systemic Delivery to the LiverMolecular Therapy, 2009
- Janus kinases in immune cell signalingImmunological Reviews, 2009
- Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primatesProceedings of the National Academy of Sciences, 2008
- A calculated response: control of inflammation by the innate immune systemJournal of Clinical Investigation, 2008
- PI3K is critical for the nuclear translocation of IRF-7 and type I IFN production by human plasmacytoid predendritic cells in response to TLR activationThe Journal of Experimental Medicine, 2008
- The Multifunctional RNA-Binding Protein La Is Required for Mouse Development and for the Establishment of EmbryonicStem CellsMolecular and Cellular Biology, 2006
- Toll-like receptor signallingNature Reviews Immunology, 2004
- siRNAs: applications in functional genomics and potential as therapeuticsNature Reviews Drug Discovery, 2004